CVS Health Corp
CVS62.470USD
+0.370+0.60%
Close 08/01, 16:00（ET）Quotes delayed by 15 min
78.84BMarket Cap
14.93P/E TTM
More Details of CVS Health Corp Company
CVS Health Corporation is a health solutions company. The Company's segments include Health Care Benefits, Health Services, Pharmacy & Consumer Wellness and Corporate/Other. The Health Care Benefits segment offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, PDPs and Medicaid health care management services. The Health Services segment provides a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home, and offers provider enablement solutions. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations, provides ancillary pharmacy services including pharmacy patient care programs, diagnostic testing and vaccination administration, and sells an assortment of health and wellness products and general merchandise.
Company Info
Ticker SymbolCVS
Company nameCVS Health Corp
IPO dateOct 01, 1952
Founded at1996
CEOMr. J. David Joyner
Number of employees300000
Security typeOrdinary Share
Fiscal year-endOct 01
Address1 Cvs Dr
CityWOONSOCKET
Stock exchangeNYSE Consolidated
CountryUnited States of America
Postal code02895-6146
Phone14017651500
Websitehttps://cvshealth.com/
Ticker SymbolCVS
IPO dateOct 01, 1952
Founded at1996
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Larry Robbins
Mr. Larry Robbins
Independent Director
Independent Director
11.95M
--
Mr. Tilak Mandadi
Mr. Tilak Mandadi
Executive Vice President, Chief Data, Digital, Analytics and Technology Officer
Executive Vice President, Chief Data, Digital, Analytics and Technology Officer
60.01K
+48.50%
Mr. Michael F. (Mike) Mahoney
Mr. Michael F. (Mike) Mahoney
Lead Independent Director
Lead Independent Director
45.91K
+0.31%
Mr. Steven H. Nelson
Mr. Steven H. Nelson
Executive Vice President and President - Aetna
Executive Vice President and President - Aetna
21.33K
--
Mr. Guy P. Sansone
Mr. Guy P. Sansone
Independent Director
Independent Director
12.01K
+15.04%
Mr. Douglas H. (Doug) Shulman, J.D.
Mr. Douglas H. (Doug) Shulman, J.D.
Independent Director
Independent Director
4.28K
+94.41%
Ms. Leslie V. Norwalk
Ms. Leslie V. Norwalk
Director
Director
4.28K
+94.41%
Mr. Roger N. Farah
Mr. Roger N. Farah
Executive Chairman of the Board
Executive Chairman of the Board
4.12K
-92.40%
Ms. Alecia A. DeCoudreaux, J.D.
Ms. Alecia A. DeCoudreaux, J.D.
Independent Director
Independent Director
2.97K
--
Dr. Amy L. Compton-Phillips, M.D.
Dr. Amy L. Compton-Phillips, M.D.
Executive Vice President and Chief Medical Officer
Executive Vice President and Chief Medical Officer
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Larry Robbins
Mr. Larry Robbins
Independent Director
Independent Director
11.95M
--
Mr. Tilak Mandadi
Mr. Tilak Mandadi
Executive Vice President, Chief Data, Digital, Analytics and Technology Officer
Executive Vice President, Chief Data, Digital, Analytics and Technology Officer
60.01K
+48.50%
Mr. Michael F. (Mike) Mahoney
Mr. Michael F. (Mike) Mahoney
Lead Independent Director
Lead Independent Director
45.91K
+0.31%
Mr. Steven H. Nelson
Mr. Steven H. Nelson
Executive Vice President and President - Aetna
Executive Vice President and President - Aetna
21.33K
--
Mr. Guy P. Sansone
Mr. Guy P. Sansone
Independent Director
Independent Director
12.01K
+15.04%
Mr. Douglas H. (Doug) Shulman, J.D.
Mr. Douglas H. (Doug) Shulman, J.D.
Independent Director
Independent Director
4.28K
+94.41%
Revenue Breakdown
Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
By BusinessUSD
Name
Revenue
Proportion
Pharmacy
52.51B
55.51%
Premiums
32.82B
34.70%
Front Store
5.24B
5.54%
Other
3.50B
3.70%
Net investment income(loss)
520.00M
0.55%
No Data
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Pharmacy
52.51B
55.51%
Premiums
32.82B
34.70%
Front Store
5.24B
5.54%
Other
3.50B
3.70%
Net investment income(loss)
520.00M
0.55%
Shareholding Stats
Updated: Thu, May 15
Updated: Thu, May 15
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
9.31%
Dodge & Cox
5.81%
Capital World Investors
5.41%
BlackRock Institutional Trust Company, N.A.
5.13%
State Street Global Advisors (US)
4.58%
Other
69.76%
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
9.31%
Dodge & Cox
5.81%
Capital World Investors
5.41%
BlackRock Institutional Trust Company, N.A.
5.13%
State Street Global Advisors (US)
4.58%
Other
69.76%
Shareholder Types
Shareholders
Proportion
Investment Advisor
46.81%
Investment Advisor/Hedge Fund
28.45%
Hedge Fund
3.63%
Research Firm
2.87%
Pension Fund
1.98%
Bank and Trust
1.94%
Sovereign Wealth Fund
1.57%
Individual Investor
1.06%
Insurance Company
0.10%
Other
11.59%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
3683
1.12B
88.27%
+7.67M
2025Q1
3787
1.12B
88.80%
+14.13M
2024Q4
3853
1.08B
85.46%
-1.57M
2024Q3
3812
1.05B
83.30%
-34.78M
2024Q2
3834
1.06B
84.02%
-4.44M
2024Q1
3863
1.03B
82.03%
-36.45M
2023Q4
3882
1.05B
81.65%
-1.13M
2023Q3
3770
1.04B
80.61%
-13.78M
2023Q2
3775
1.03B
80.60%
-13.09M
2023Q1
3785
1.03B
80.72%
-44.48M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
The Vanguard Group, Inc.
117.73M
9.31%
+968.46K
+0.83%
Mar 31, 2025
Dodge & Cox
73.46M
5.81%
+3.35M
+4.78%
Mar 31, 2025
Capital World Investors
68.40M
5.41%
+7.36M
+12.06%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
64.96M
5.13%
+4.87M
+8.11%
Mar 31, 2025
State Street Global Advisors (US)
57.99M
4.58%
+1.04M
+1.82%
Mar 31, 2025
Geode Capital Management, L.L.C.
27.96M
2.21%
+907.87K
+3.36%
Mar 31, 2025
Capital International Investors
26.19M
2.07%
-478.74K
-1.80%
Mar 31, 2025
Fidelity Management & Research Company LLC
24.22M
1.91%
+3.08M
+14.57%
Mar 31, 2025
Capital Research Global Investors
18.73M
1.48%
+16.22M
+647.44%
Mar 31, 2025
Norges Bank Investment Management (NBIM)
18.70M
1.48%
+3.80M
+25.51%
Dec 31, 2024
View more
Related ETFs
Updated: Sun, Jul 6
Updated: Sun, Jul 6
Name
Proportion
Davis Select US Equity ETF
5.18%
Invesco S&P Ultra Dividend Revenue ETF
4.72%
iShares U.S. Healthcare Providers ETF
4.71%
VanEck Retail ETF
4.2%
iShares US Consumer Staples ETF
3.65%
Brookstone Value Stock ETF
3.54%
Invesco S&P 500 Enhanced Value ETF
3.47%
Invesco S&P 500 Pure Value ETF
3.23%
First Trust Consumer Staples Alphadex Fund
3.23%
Leatherback Long/Short Alternative Yield ETF
3.02%
View more
Davis Select US Equity ETF
Proportion5.18%
Invesco S&P Ultra Dividend Revenue ETF
Proportion4.72%
iShares U.S. Healthcare Providers ETF
Proportion4.71%
VanEck Retail ETF
Proportion4.2%
iShares US Consumer Staples ETF
Proportion3.65%
Brookstone Value Stock ETF
Proportion3.54%
Invesco S&P 500 Enhanced Value ETF
Proportion3.47%
Invesco S&P 500 Pure Value ETF
Proportion3.23%
First Trust Consumer Staples Alphadex Fund
Proportion3.23%
Leatherback Long/Short Alternative Yield ETF
Proportion3.02%
Dividend
A total of
14.66B
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
Jan 03, 2025
CVS.NB Interim Cash Dividend of gross USD 0.665 paid on Feb 03, 2025 going ex on Jan 23, 2025
Jan 23, 2025
Feb 03, 2025
Jan 23, 2025
Sep 19, 2024
CVS.NB Final Cash Dividend of gross USD 0.665 paid on Nov 01, 2024 going ex on Oct 21, 2024
Oct 21, 2024
Nov 01, 2024
Oct 21, 2024
Jul 08, 2024
CVS.NB Interim Cash Dividend of gross USD 0.665 paid on Aug 01, 2024 going ex on Jul 22, 2024
Jul 22, 2024
Aug 01, 2024
Jul 22, 2024
Mar 21, 2024
CVS.NB Interim Cash Dividend of gross USD 0.665 paid on May 01, 2024 going ex on Apr 19, 2024
Apr 22, 2024
May 01, 2024
Apr 19, 2024
Dec 06, 2023
CVS.NB Interim Cash Dividend of gross USD 0.665 paid on Feb 01, 2024 going ex on Jan 19, 2024
Jan 22, 2024
Feb 01, 2024
Jan 19, 2024
Sep 21, 2023
CVS.NB Final Cash Dividend of gross USD 0.605 paid on Nov 01, 2023 going ex on Oct 19, 2023
Oct 20, 2023
Nov 01, 2023
Oct 19, 2023
Jul 07, 2023
CVS.NB Interim Cash Dividend of gross USD 0.605 paid on Aug 01, 2023 going ex on Jul 20, 2023
Jul 21, 2023
Aug 01, 2023
Jul 20, 2023
Mar 16, 2023
CVS.NB Interim Cash Dividend of gross USD 0.605 paid on May 01, 2023 going ex on Apr 20, 2023
Apr 21, 2023
May 01, 2023
Apr 20, 2023
Dec 15, 2022
CVS.NB Interim Cash Dividend of gross USD 0.605 paid on Feb 01, 2023 going ex on Jan 19, 2023
Jan 20, 2023
Feb 01, 2023
Jan 19, 2023
Sep 21, 2022
CVS.NB Final Cash Dividend of gross USD 0.55 paid on Nov 01, 2022 going ex on Oct 20, 2022
Oct 21, 2022
Nov 01, 2022
Oct 20, 2022
View more
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
